5.74% 0.7895

Hutchmed China Limited Adr (HCM)

概要ニュース株価時系列オプションチェーンディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Hutchmed China Limited Adr Stock (HCM) Company Profile

Hutchmed China Limited Adr

Healthcare (1119)

HCM's Discussions on Twitter

HCM を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
HCM Hutchmed China Limited Adr	14.54	2.36B	603.63M	468.71M	-59.92M	2.682
ZTS Zoetis Inc	127.95	57.00B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.95	49.88B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.09	45.73B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.33	36.84B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	506.94	21.64B	3.08B	1.24B	1.07B	25.61

Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-09-22	ダウングレード	Morgan Stanley	Equal-Weight → Underweight
2025-05-13	ダウングレード	HSBC Securities	Buy → Hold
2023-11-24	アップグレード	Deutsche Bank	Hold → Buy
2022-05-04	ダウングレード	Deutsche Bank	Buy → Hold
2021-09-22	ダウングレード	Goldman	Buy → Neutral
2021-08-03	開始されました	Jefferies	Buy
2020-10-02	開始されました	Deutsche Bank	Buy
2020-03-13	開始されました	Cantor Fitzgerald	Overweight
2020-02-20	開始されました	Goldman	Buy
2019-11-19	開始されました	CLSA	Buy
2019-10-23	繰り返されました	BofA/Merrill	Buy
2019-07-05	開始されました	Macquarie	Outperform

Hutchmed China Limited Adr (HCM) 最新ニュース

Hutchmed China Limited Adr (HCM) 財務データ

Hutchmed China Limited Adr (HCM)

Hutchmed China Limited Adr Stock (HCM) Company Profile

HCM を他の銘柄と比較する

Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades

Hutchmed China Limited Adr (HCM) 最新ニュース

HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China - GlobeNewswire Inc.

HUTCHMED (LON:HCM) Share Price Passes Below 200-Day Moving Average – Here’s What Happened - Defense World

HUTCHMED (NASDAQ:HCM) Sees Strong Trading Volume – Should You Buy? - Defense World

MACD Signals Flash Warning for The Hindustan Housing Company Limited StockMarket Entry Points & Free Navigate Market With Precision - bollywoodhelpline.com

HUTCHMED (NASDAQ:HCM) Sees Large Volume IncreaseShould You Buy? - MarketBeat

[6-K] HUTCHMED (China) Ltd Current Report (Foreign Issuer) | HCM SEC FilingForm 6-K - Stock Titan

REGHutchmed China LtdBlocklisting Six Monthly Return - TradingView — Track All Markets

HUTCHMED (NASDAQ:HCM) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Brokerages Set HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Target Price at $20.88 - Defense World

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors - GlobeNewswire

Bearish block trade of HUTCHMED(00013) 278.5K shares at $22.0, $6.127M turnover - AASTOCKS.com

Schroder Investment Management Group Has $38.82 Million Stock Holdings in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

HUTCHMED Share Movement in the (LSE:HCM) Landscape and FTSE Aim 100 - Kalkine Media

Forge Global Holdings, Inc. (NYSE:FRGE) Receives $42.00 Average Price Target from Analysts - Defense World

Rep. Lisa C. McClain Sells Off Shares of Gartner, Inc. (NYSE:IT) - Defense World

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Catalyst Funds Management Pty Ltd Sells 29,903 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

ABN Amro Investment Solutions Invests $962,000 in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

HMPL-A251 combines HER2 targeting with precision payload - BioWorld MedTech

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - The Globe and Mail

Transcript : HUTCHMED Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025, Nov-04-2025 08 - MarketScreener

HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025Slideshow (NASDAQ:HCM) 2025-11-04 - Seeking Alpha

Hutchmed Strengthens Position Within FTSE AIM 100 Index Healthcare Sphere - Kalkine Media

Hutchmed takes wraps off expanding oncology pipeline - Sharecast.com

Market news - investments.halifax.co.uk

RCSHutchmed China LtdUpdates from R&D Event - TradingView

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event - The Manila Times

ETFs Investing in HUTCHMED (China) Limited Sponsored ADR Stocks - TradingView

CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Manila Times

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - Macau Business

International companies to host live webcasts at Deutsche - GlobeNewswire

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Vanguard Personalized Indexing Management LLC Buys 4,773 Shares of Cleanspark, Inc. $CLSK - Defense World

Vanguard Personalized Indexing Management LLC Sells 354 Shares of Cathay General Bancorp $CATY - Defense World

Hutchmed upbeat on preclinical data for novel cancer therapy - Sharecast.com

HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - The Manila Times

HUTCHMED Highlights HMPL-A251 Data Presented at the - GlobeNewswire

Allianz Asset Management GmbH Sells 80,000 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

Will Can Fite Biopharma Ltd Sponsored ADR stock benefit from mergersQuarterly Risk Review & Risk Controlled Stock Alerts - Trung tâm Dự báo KTTV quốc gia

Working capital per share of HUTCHMED (China) Limited Sponsored ADR – LSE:0J7G - TradingView

Pfizer: CN Biopharma Sector Shows Astonishing Growth; US Drug Industry Must Collaborate with CN - AASTOCKS.com

Hutchmed China Limited Adr (HCM) 財務データ

収益

当期純利益

現金流量

EPS

HCMに似た銘柄